DEXTRAN 6% IN 5% DEXTROSE INJECTION 50 MG
DEXTROSE : 50 MG DEXTRAN : 60 MG · DIN 00224219 · HOSPIRA HEALTHCARE ULC
Health Canada status: CANCELLED POST MARKET
What is DEXTRAN 6% IN 5% DEXTROSE INJECTION?
DEXTRAN 6% IN 5% DEXTROSE INJECTION 50 MG contains DEXTROSE : 50 MG DEXTRAN : 60 MG. It is listed in the Health Canada Drug Product Database under DIN 00224219, held by HOSPIRA HEALTHCARE ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00224219 |
|---|---|
| Brand name | DEXTRAN 6% IN 5% DEXTROSE INJECTION |
| Generic / active ingredient | DEXTROSE : 50 MG DEXTRAN : 60 MG |
| Manufacturer | HOSPIRA HEALTHCARE ULC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05AA55 DEXTRAN,COMBINATIONS |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2012 |
| Original market date | 1955-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05AA55 DEXTRAN,COMBINATIONS. 2 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LMD 10% IN 0.9% SODIUM CHLORIDE | 0.9 % | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00224227 |
| LMD 10% IN DEXTROSE 5% | 10 % | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00224235 |
| 10% DEXTRAN 40 IN 0.9% SODIUM CHLORIDE INJECTION | 0.9 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924206 |
| 10% DEXTRAN 40 IN 5% DEXTROSE INJECTION | 5 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924249 |
| 6% DEXTRAN 70 IN 0.9% SODIUM CHLORIDE INJECTION | 6 % | SOLUTION | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 01924192 |
| DEXTRAN 6% IN 0.9% SODIUM CHLORIDE INJECTION | 9 MG | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00225436 |
| GENTRAN 40 10% DEXTROSE 5% INJ | 10 G / 100 ML | LIQUID | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 00454915 |
| GENTRAN 40 10% SODIUM CHLORIDE 0.9% INJ | 10 G / 100 ML | LIQUID | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 00454923 |
| GENTRAN-70 6% & SODIUM CHLORIDE 0.9% INJ | .9 % | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 01981722 |
| MACRODEX 6% IN DEXTROSE | 6 G / 100 ML | LIQUID | PHARMACIA (CANADA) INC. | CANCELLED POST MARKET | DIN 00158542 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.